13F

Stock

Tg Therapeutics, Inc.

TGTX · held by 5 managers

Reported value

$17.9M

Holders

5

+0 new · −0 exited

Holders’ est. mark

$3.98M

Price effect on 5 books still in the name

Largest holder

$9.56M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC317.6K$9.56M$2.13MAdded$1.44M
Marex Group plc275K$8.28M$1.85MAdded$1.85M
Leonteq Securities AG1.25K$37.5K$4.36KAdded$22.3K
DANSKE BANK A/S200$6.02K$1.34KCut−$12.7K
Prestige Wealth Management Group LLC100$3.01K$671Added$671

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.